DexCom, Inc.
DXCM
$73.43
-$0.95-1.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.16% | 4.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.16% | 4.51% | |||
| Cost of Revenue | -2.30% | 2.05% | |||
| Gross Profit | 8.38% | 6.18% | |||
| SG&A Expenses | -2.99% | 1.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.12% | 2.36% | |||
| Operating Income | 33.20% | 14.06% | |||
| Income Before Tax | -3.29% | 46.12% | |||
| Income Tax Expenses | 7.15% | 11.75% | |||
| Earnings from Continuing Operations | -5.81% | 57.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.81% | 57.84% | |||
| EBIT | 33.20% | 14.06% | |||
| EBITDA | 26.82% | 11.07% | |||
| EPS Basic | -4.74% | 58.22% | |||
| Normalized Basic EPS | -2.18% | 46.50% | |||
| EPS Diluted | -3.89% | 57.17% | |||
| Normalized Diluted EPS | -1.24% | 46.40% | |||
| Average Basic Shares Outstanding | -1.13% | -0.26% | |||
| Average Diluted Shares Outstanding | -2.09% | -0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||